Hap Trading, LLC Novavax Inc Call Options Transaction History

Hap Trading, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $341,996 - $966,544	-38,600 Reduced 36.69%	66,600 $7,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1.7 Million - $7.11 Million	93,400 Added 791.53%	105,200 $11,000
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $141,492 - $293,631	-3,900 Reduced 24.84%	11,800 $51,000
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $2.21 Million - $4.53 Million	-31,700 Reduced 66.88%	15,700 $44,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $659,344 - $1.07 Million	4,900 Added 11.53%	47,400 $2.82 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $497,840 - $757,624	2,800 Added 7.05%	42,500 $4.01 Million
Q2 2021 Aug 11, 2021	SELL	$121.0 - $257.67 $6.91 Million - $14.7 Million	-57,100 Reduced 58.99%	39,700 $4.54 Million
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $1.4 Million - $3.97 Million	12,400 Added 14.69%	96,800 $5.88 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $4.1 Million - $7.27 Million	52,100 Added 161.3%	84,400 $1.79 Million
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $39,720 - $89,255	-500 Reduced 1.52%	32,300 $1.36 Million
Q2 2020 Aug 10, 2020	SELL	$13.86 - $83.61 $110,880 - $668,880	-8,000 Reduced 19.61%	32,800 $1.5 Million
Q1 2020 May 08, 2020	BUY	$3.93 - $16.0 $26,704 - $108,720	6,795 Added 19.98%	40,800 $165,000
Q4 2019 Feb 11, 2020	BUY	$3.69 - $5.22 $58,671 - $82,998	15,900 Added 87.82%	34,005 $18,000
Q3 2019 Nov 12, 2019	BUY	$4.02 - $7.84 $72,782 - $141,943	18,105 New	18,105 $20,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.